SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

U.S. Stem Cell Inc. (USRM)

Add USRM Price Alert      Hide Sticky   Hide Intro
Moderator: TheHungryHippo, Papa Bear, BluSkies, StaleyCornell, buythebuy, mtlebomac
Search This Board: 
Last Post: 5/25/2017 10:06:31 AM - Followers: 866 - Board type: Free - Posts Today: 90



Bioheart, Inc. is committed to the discovery and development of autologous cellular therapies to treat a variety of degenerative diseases, as well as the continuation of our ongoing research for the treatment of heart failure, cardiovascular and perioheral vascular disease. 


The US. Stem Cell Inc. Vision
Our vision is to improve the quality of patients’ lives, while reducing hospitalizations and healthcare costs. 
Bioheart is and will continue to be recognized by physicians and patients as the world’s leader in providing 
innovative treatment and management of patients with severe cardiovascular and peripheral vascular 
disease.We are also focused on the discovery, development and commercialization of autologous cell therapies 
for the treatment of degenerative diseases.




Mike Tomás

President & CEO

Mike Tomas. Mr. Mike Tomas was appointed President and Chief Executive Officer and a member of our Board of Directors on June 19, 2010. Mike Tomas was appointed as the Company’s President and Chief Executive Officer, and as a director on June 19, 2010. Mr. Tomas has been President for the past nine years of The ASTRI Group, an early stage private equity investment company in Florida with an investment in Bioheart since 2001. In 2003, he joined Bioheart’s Board of Directors as the independent representative of The ASTRI Group. ASTRI provides capital, business development and strategic marketing support to emerging private companies. Mr. Tomas will continue to serve as President of The ASTRI Group. Previously from 1983 to 2001, Mr. Tomas held ascending executive positions including Chief Marketing Officer at Avantel, a $1 billion dollar joint venture with MCI. Upon retiring from MCI and WorldCom, Tomas joined other ex-MCI executives and helped raise $40M in venture capital to form Ineto, an integrated customer communications software solution that was successfully sold in 2001.
Mr. Tomas sits on the boards of Avisena (revenue cycle management company for medical practices), SilverSky (fka Perimeter Internetworking) (SaaS/managed security services provider for medical practices and financial institutions), Rokk3r Labs (a digital and mobile products developer and portfolio), Bioheart (adult stem cell development for heart muscle tissue repair) and is the current chairman of Florida International University’s Global Entrepreneurship Center. He is an inductee into the Miami-Dade College and WACE Halls of Fame for business, an FIU Torch Award winner — and winner of top communications, medical innovations, education and entrepreneurial awards. Mr. Tomas holds a Masters of Business Administration from the University of Miami and a Bachelor’s degree from Florida International University.

Kristin Comella

Chief Scientific Officer

Kristin Comella. Ms. Comella was appointed Chief Scientific Officer in September 2010. Ms. Comella has served as our Vice President of R&D and Corporate Development since December 2008 and has played a major role in managing our product development, manufacturing and quality systems since joining Bioheart in 2004. Ms. Comella has 15 years of industry experience with expertise in regenerative medicine, training and education, research and product development, and currently serves on multiple advisory boards in the stem cell arena. Ms. Comella has many years of cell culturing experience including building and managing the stem cell laboratory at Tulane University's Center for Gene Therapy and developing stem cell therapies for osteoarthritis at Osiris Therapeutics. Ms. Comella holds an M.S. in Chemical Engineering from The Ohio State University and a B.S. in Chemical Engineering from the University of South Florida.  On March 12, 2013, Kristin Comella was appointed to serve as a member of our Board of Directors.

Dr. William P. Murphy, Jr.

William P. Murphy, Jr., M.D. Dr. Murphy has served as a member of our Board of Directors since June 2003. Dr. Murphy founded Small Parts, Inc., a supplier of high quality mechanical components for design engineers, in 1964 and served as its Chairman until his retirement in April 2005. Small Parts, Inc. was acquired by, Inc. in March 2005. From October 1999 until October 2004, Dr. Murphy served as the Chairman and Chief Executive Officer of Hyperion, Inc., a medical diagnosis company which had an involuntary bankruptcy filed against it in December 2003. Dr. Murphy is the founder of Cordis Corporation (now Cordis Johnson & Johnson) which he led as President, Chairman and Chief Executive Officer at various times during his 28 years at Cordis until his retirement in October 1985. Cordis Johnson & Johnson is a leading firm in cardiovascular instrumentation. Dr. Murphy received an M.D. in 1947 from the University of Illinois and a B.S in pre-medicine from Harvard College in 1946. He also studied physiologic instrumentation at Massachusetts Institute of Technology, or MIT. After a two year rotating internship at St. Francis Hospital in Honolulu, he became a Research Fellow in Medicine at the Peter Bent Brigham Hospital in Boston where he was the dialysis engineer on the first clinical dialysis team in the United States. He continued as an Instructor in Medicine and then a research associate in Medicine at Harvard Medical School. Dr. Murphy is the author of numerous papers and owns 17 patents. He is the recipient of a number of honors, including the prestigious Lemelson-MIT Lifetime Achievement Award, the MIT Corporate Leadership Award, the Distinguished Service Award from North American Society of Pacing and Electrophysiology, and the Jay Malina Award from the Beacon Council of Miami, Florida. He is also a member of the Inventors Hall of Fame


Executive Officers and Directors

Set forth below is information regarding our executive officers and directors as of December 31, 2013

Mike Tomas 48 Director, President and Chief Executive Officer, Chief Financial Officer
William P. Murphy, Jr., M.D. 90 Director, Chairman of the Board
Mark P. Borman  59  Director
Charles A. Hart  53 Director
Sam Ahn  59 Director
Kristen Comella  37 Director, Chief Scientific Officer
Sheldon T. Anderson 63 Director


Business Strategy

 Our principal objective is to become a leading regenerative medicine company that discovers, develops and commercializes novel, autologous cell therapies, and related devices, for the treatment and improved care of patients suffering from chronic and acute heart damage as well as lower limb ischemia. Our secondary objective is the discovery, development and commercialization of autologous cell therapies for the treatment of degenerative diseases.  The number of heart failure patients is expected to increase from 25 million worldwide today to over 50 million in five years. Our focus is on serving these patients. To achieve our primary objective, we plan to pursue the following strategies:

  • - Obtain initial regulatory approval of MyoCell and/or MyoCell SDF-1 by targeting patients with severe heart damage. 
    - Continue existing studies with adipose derived stem cells and endothelial progenitor cells.
    - Continue to develop our pipeline of cell-based therapies and related devices for the treatment of chronic and acute heart damage. 
    - Develop our sales and marketing capabilities. 
    - Continue to refine our MyoCell and MyoCell SDF-1 cell culturing processes.
    - Expand and enhance our intellectual property rights.
    - License, acquire and/or develop complementary products and technologies. 

USRM - Daily Candlesticks


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
USRM News: Quarterly Report (10-q) 05/02/2017 04:06:21 PM
USRM News: Significant Updates on the Following Companies and New Coverage 04/20/2017 09:00:00 AM
USRM News: Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth 04/12/2017 08:49:04 AM
USRM News: Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth 04/12/2017 08:47:59 AM
USRM News: Statement of Changes in Beneficial Ownership (4) 03/31/2017 04:02:24 PM
#59623  Sticky Note TOP TEN REASONS I'M LONG ON $USRM RIGHT NOW. TheHungryHippo 05/13/17 01:34:26 AM
#52397  Sticky Note This is the guy who is investing up Vita Nova Stocks 04/15/17 09:22:22 AM
#42457  Sticky Note THIS IS A MUST READ slam4202 03/30/17 07:05:37 AM
#26891  Sticky Note $USRM ALL IN ONE DD Post for Investors: TheHungryHippo 03/09/17 05:25:50 AM
#26168  Sticky Note Thoughts? BluSkies 03/07/17 09:49:57 PM
#63793   USRM everybody is unloading RMAT must be denied BoilerRoom 05/25/17 10:15:19 AM
#63792   Smoke and mirrors MM's can do what they 11JR11 05/25/17 10:14:56 AM
#63791   SLAP FKN ASK!!!!! massivegains10 05/25/17 10:14:54 AM
#63790   I can't wait to see these shorts Fry! DTGoody 05/25/17 10:14:07 AM
#63789   adding massivegains10 05/25/17 10:14:05 AM
#63788   USRM dilution BoilerRoom 05/25/17 10:13:42 AM
#63787   ask gets hit and size does not even change..... massivegains10 05/25/17 10:12:13 AM
#63786   USRM Boiler always right this POS keeps dropping BoilerRoom 05/25/17 10:10:21 AM
#63785   I don't give one chit about you or 11JR11 05/25/17 10:06:31 AM
#63784   Release the MFing KRACKEN!!!! CaptainObvious2017 05/25/17 09:59:17 AM
#63783   Meaning if you are going to personally comment LoserTrying2Win 05/25/17 09:59:12 AM
#63782   Keep up what? Are you threating to 11JR11 05/25/17 09:57:35 AM
#63781   IF this thing doesn't have news of RMAT fourcloze 05/25/17 09:55:58 AM
#63779   .105 broke of course it might dip into 0mn1 05/25/17 09:53:00 AM
#63776   Is it still Green on the week or nah? LoserTrying2Win 05/25/17 09:43:31 AM
#63775   Let's panic for no reason!! Man it blows In2winsumdin 05/25/17 09:43:09 AM
#63774   REGEN trial, CEO DEFUNDED, PATIENT SAFETY CONCERNS: Hornet Driver 05/25/17 09:42:00 AM
#63773   Giant Spread....MMs banking on panic selling into their LoserTrying2Win 05/25/17 09:41:04 AM
#63772   Now I told you guys this would be CaptainObvious2017 05/25/17 09:41:00 AM
#63771   My thought exactly. NoMoDo 05/25/17 09:38:56 AM
#63770   I don't watch his charts. I do zturk 05/25/17 09:36:36 AM
#63768   MARVEL STUDY SUSPENDED 2010 "LACK OF FUNDING": Hornet Driver 05/25/17 09:34:52 AM
#63767   It really depends, a lot of his charts Archery Class 05/25/17 09:28:32 AM
#63766   From Bow-tie to Shadow, Back at you CAT$$$ bow-tie 05/25/17 09:28:32 AM
#63765   Shadow (my cat) says good morning. Zues 05/25/17 09:27:00 AM
#63764   Lol! OH GAWD! rising 05/25/17 09:25:42 AM
#63763   RELEASE THE KRAKEN!! GO USRM Ryguy008 05/25/17 09:24:33 AM
#63762   You know me Bro, Always up early Bright bow-tie 05/25/17 09:24:25 AM
#63761   What happens if there's no approval from the FDA? joeeasy 05/25/17 09:24:09 AM
#63760   Lmao .. watched the sun come up while sorc92 05/25/17 09:23:22 AM
#63759   Gee, talk about getting up early Work Harder 05/25/17 09:20:32 AM
#63758   He is allowed to post as many as 11JR11 05/25/17 09:17:05 AM
#63757   Thank-You AC, Go USRM$$$ bow-tie 05/25/17 09:14:53 AM
#63756   I know..I just usually see his posts after LoserTrying2Win 05/25/17 09:10:39 AM
#63755   His videos are the most generic videos ive dtx180 05/25/17 09:10:35 AM
#63754   Good morning! Has been following a good 2 steps Archery Class 05/25/17 09:10:31 AM
#63753   Good Morning USRM$$$ bow-tie 05/25/17 09:09:32 AM
#63752   I take it as fact as well, and 11JR11 05/25/17 09:08:13 AM
#63751   Means he wants you to watch his video NoMoDo 05/25/17 09:07:05 AM
#63750   Me too docprep 05/25/17 09:05:59 AM
#63749   Good Morning Work Hard!!!! Thank you in advance. powerbar03 05/25/17 09:03:49 AM
#63747   Not a conspiracy theory 11JR11,simply reality.IMO the Oligarchs joeeasy 05/25/17 09:01:31 AM
#63746   Not sure it would matter. $USRM 11JR11 05/25/17 08:59:39 AM
#63745   What do you think will happen if the Muskey47 05/25/17 08:57:56 AM
#63744   A morning Clay Video post? What does LoserTrying2Win 05/25/17 08:57:50 AM
#63743   * * $USRM Video Chart 05-24-17 * * ClayTrader 05/25/17 08:54:50 AM
#63742   This could be good or bad. Excited but Wolfe64 05/25/17 08:54:19 AM
#63741   I'm ready . Bring it. Time to start sorc92 05/25/17 08:50:05 AM
#63739   Considering putting up Work Harder 05/25/17 08:46:28 AM
#63738   I,m usually up early Work Harder 05/25/17 08:45:22 AM